The role of Bcl-2 expression in EGF inhibition of TNF-alpha/IFN-gamma-induced villous trophoblast apoptosis.
The inflammatory cytokines tumour necrosis factor alpha (TNF-alpha) and immune interferon gamma (IFN-gamma) stimulate villous cytotrophoblast apoptosis while epidermal growth factor (EGF) protects. We hypothesize that TNF-alpha, IFN-gamma and EGF regulate apoptosis in part by modulating cellular expression levels of the anti-death gene bcl-2. While Bcl-2 is reported to be strongly expressed in villous syncytiotrophoblasts, it is not known whether the protein is expressed in cultured villous cytotrophoblasts (CT) and, if so, whether it is functional. We show by Northern blot analysis that bcl-2 mRNA is expressed in cultured CT and by immunoblot analysis that the protein is strongly expressed in highly purified first trimester and term villous cytotrophoblasts. The expression levels of Bcl-2 protein were the same in first trimester and term cytotrophoblasts. Culture with TNF-alpha/IFN-gamma and EGF did not alter expression of either Bcl-2 protein or of the pro-apoptotic Bcl-2 family member Bak. Double label flow cytometric analysis that measured apoptosis and Bcl-2 content simultaneously showed that cells expressing low levels of Bcl-2 underwent TNF-alpha/IFN-gamma-induced apoptosis at a higher frequency than cells expressing lower levels. We conclude that Bcl-2 is expressed in cytotrophoblasts, that its expression is constitutive and that modulation of its expression levels does not mediate cytokine and growth factor regulation of apoptosis in these cells.
Ho
S
S
Department of Medical Microbiology and Immunology, University of Alberta Perinatal Research Centre, Canada.
Winkler-Lowen
B
B
Morrish
D W
DW
Dakour
J
J
Li
H
H
Guilbert
L J
LJ
D017209:Apoptosis / Q000187:drug effects; D002478:Cells, Cultured; D002824:Chorionic Villi / Q000187:drug effects* / Q000473:pathology; D016207:Cytokines / Q000037:antagonists & inhibitors*; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D005260:Female; D018507:Gene Expression Regulation, Developmental / Q000502:physiology*; D019254:Genes, bcl-2; D006801:Humans; D007371:Interferon-gamma / Q000037:antagonists & inhibitors; D008565:Membrane Proteins / Q000378:metabolism; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000378:metabolism; D011261:Pregnancy Trimester, First; D011263:Pregnancy Trimester, Third; D014327:Trophoblasts / Q000473:pathology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D050998:bcl-2 Homologous Antagonist-Killer Protein
C494772:BAK1 protein, human; D016207:Cytokines; D008565:Membrane Proteins; D011257:Pregnancy Proteins; D014409:Tumor Necrosis Factor-alpha; D050998:bcl-2 Homologous Antagonist-Killer Protein; D004815:Epidermal Growth Factor; D007371:Interferon-gamma